← Eichor
Condition: Neoplasm Trophoblastic Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Neoplasm Trophoblastic

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule
NA · 1 location(s) · Women's Hospital School Of Medicine Zhejiang University · NCT03785574
Iparomlimab and Tuvonralimab (QL1706) for Intermediate Trophoblastic Tumors
Phase 1/Phase 2 · 1 location(s) · Peking Union Medical College Hospital · NCT06941766
The Psychological Impact of GTN on Women Who Have Completed Chemotherapy Treatment
Phase N/A · 1 location(s) · Sheffield Teaching Hospitals NHS Foundation Trust · NCT06169644
Avelumab and Methotrexate in in Low-risk Gestational Trophoblastic Neoplasias as First Line Treatment
Phase 1/Phase 2 · 9 location(s) · Hospices Civils de Lyon · NCT04396223
A Multi-center Cohort Study of Hydatidiform Mole in China (CN-HM-01)
Phase N/A · 14 location(s) · Obstetrics & Gynecology Hospital of Fudan University · NCT07202728
Toripalimab Plus Actinomycin-D as Fist-Line Treatment for GTN With FIGO Score 5-6
NA · 1 location(s) · Peking Union Medical College Hospital · NCT06028672
A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation for Post-molar Gestational Trophoblastic Neoplasi
Phase 2 · 1 location(s) · Imperial College London · NCT05635344
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
Phase 2 · 166 location(s) · Children's Oncology Group · NCT04684368
Toripalimab Plus Actinomycin-D As Fist-Line Treatment for GTN with FIGO Score 7
Phase 2 · 1 location(s) · Peking Union Medical College Hospital · NCT06020755
High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors
Phase 2 · 1 location(s) · N.N. Petrov National Medical Research Center of Oncology · NCT06418789
Agnostic Therapy in Rare Solid Tumors
Phase 2 · 8 location(s) · Instituto do Cancer do Estado de São Paulo · NCT06638931
Clinical Specialty Queue For Gestational Trophoblastic Neoplasia
Phase N/A · 1 location(s) · Women's Hospital School Of Medicine Zhejiang University · NCT06681259
Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neop
Phase 3 · 1 location(s) · Women's Hospital School Of Medicine Zhejiang University · NCT03703271
ASk Questions in GYnecologic Oncology (ASQ-GYO)
NA · 1 location(s) · Ira Winer · NCT06339827
Molecular Epidemiology of Pediatric Germ Cell Tumors
Phase N/A · 1 location(s) · Children's Oncology Group · NCT05564026
Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06161532
The French National Reference Centre of GTD
Phase N/A · 1 location(s) · Hospices Civils de Lyon · NCT02892877
Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia
Phase 2 · 1 location(s) · Peking Union Medical College Hospital · NCT05139095
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.